Suraksha Diagnostic approved audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026.
Board recommended a dividend of ₹0.50 per share (25% on face value of ₹2) for FY25-26, subject to shareholder approval.
Appointed M/s. Suresh Surana & Associates LLP as Internal Auditor and reappointed M/s. S Chhaparia & Associates as Cost Auditor for FY26-27.
Record date for dividend entitlement fixed as 26 August 2026, with AGM scheduled for 02 September 2026.